Utilizing biotechnological aassays such as GPCR-specific PCR, RNA-seq, database mining, and analysis would definitely help to describe the expression of GPCR in primary cancer cells, cancer cell lines, cells in tumor tissue, and the tumor microenvironment. The gene discussed is LPAR3; the disease is neoplasm.